New innovations and service capabilities are latest milestone in autonomous pharmacy roadmap designed to create a zero-error, fully automated medication management infrastructure.
Omnicell, Inc. (NASDAQ: OMCL) announces results for its third quarter ended September 30, 2019.
Combination of Technology and Intelligence Designed to Enable Pharmacists to Operate at the Top of Their License and Provide Best Possible Patient Care
Kentucky-based Med Center Health Will Upgrade to Omnicell XT Automated Dispensing Cabinets to Digitize and Automate Medication Management Throughout its Health System
Leading Health System to Leverage Automation for Enhanced Efficiency and Safety in Central Pharmacy Operations and Clinical Care
Implementation of Automated Dispensing Cabinets and Interoperability with Electronic Health Record Streamlines Workflow, Supports Medication Safety
Omnicell, Inc. (NASDAQ: OMCL) announces results for its second quarter ended June 30, 2019.
Combination of Automation and Data Analytics Will Enhance Control and Efficiency to Free Up Pharmacists to Support Patient Care
Combination of Technology and Intelligence Will Help Enhance Safety, Control and Efficiency
New Central Distribution Center Incorporates Automation Solutions Designed to Help Enhance Quality and Safety Across Existing and Newly Acquired Facilities
High Quality Design of New easyblist fill2light Supports Safety and Efficiency in Medication Packaging
Omnicell UK Launches Vision for Autonomous Pharmacy at Clinical Pharmacy Congress
Automation of Processes Supports More Cost-effective Sterile Compounding and Improved Workflows in Patient Care Areas
Extension of Partnership Leverages Automation to Support Central Pharmacy Operations and Patient Care Initiatives
Council Member Brandi Gabbard of District 2 to Join Company Leadership for May 1st Dedication Ceremony
Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2019.